Free Trial
NASDAQ:PRVA

Privia Health Group (PRVA) Stock Price, News & Analysis

Privia Health Group logo
$23.18 -0.01 (-0.05%)
As of 01:12 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Privia Health Group Stock (NASDAQ:PRVA)

Key Stats

Today's Range
$22.99
$23.36
50-Day Range
$18.86
$23.19
52-Week Range
$16.47
$26.09
Volume
165,392 shs
Average Volume
834,738 shs
Market Capitalization
$2.84 billion
P/E Ratio
210.56
Dividend Yield
N/A
Price Target
$28.08
Consensus Rating
Moderate Buy

Company Overview

Privia Health Group Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
78th Percentile Overall Score

PRVA MarketRank™: 

Privia Health Group scored higher than 78% of companies evaluated by MarketBeat, and ranked 248th out of 941 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Privia Health Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.93, and is based on 11 buy ratings, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Privia Health Group has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Privia Health Group's stock forecast and price target.
  • Earnings Growth

    Earnings for Privia Health Group are expected to grow by 92.86% in the coming year, from $0.14 to $0.27 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Privia Health Group is 209.88, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 269.81.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Privia Health Group is 209.88, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 83.05.

  • Price to Earnings Growth Ratio

    Privia Health Group has a PEG Ratio of 3.37. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Privia Health Group has a P/B Ratio of 3.86. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Privia Health Group's valuation and earnings.
  • Percentage of Shares Shorted

    3.21% of the float of Privia Health Group has been sold short.
  • Short Interest Ratio / Days to Cover

    Privia Health Group has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Privia Health Group has recently increased by 0.92%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Privia Health Group does not currently pay a dividend.

  • Dividend Growth

    Privia Health Group does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.21% of the float of Privia Health Group has been sold short.
  • Short Interest Ratio / Days to Cover

    Privia Health Group has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Privia Health Group has recently increased by 0.92%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Privia Health Group has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 13 news articles for Privia Health Group this week, compared to 5 articles on an average week.
  • MarketBeat Follows

    1 people have added Privia Health Group to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Privia Health Group insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    10.70% of the stock of Privia Health Group is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    94.48% of the stock of Privia Health Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Privia Health Group's insider trading history.
Receive PRVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Privia Health Group and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PRVA Stock News Headlines

Why Is Privia Health (PRVA) Stock Soaring Today
One tiny company just cracked Google’s $19B problem
For decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. Then an MIT team cracked the code… dropping the cost from $63,000 to just 90 cents per gram. Now, one US-based factory is gearing up to supply the AI, aerospace, and EV industries with the one material they can’t continue to grow without. Only one company controls it, and its stock is still flying under Main Street’s radar.tc pixel
Privia Health Group (PRVA) Gets a Buy from Piper Sandler
See More Headlines

PRVA Stock Analysis - Frequently Asked Questions

Privia Health Group's stock was trading at $19.55 at the start of the year. Since then, PRVA stock has increased by 18.1% and is now trading at $23.0850.

Privia Health Group, Inc. (NASDAQ:PRVA) released its quarterly earnings results on Thursday, August, 7th. The company reported $0.02 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.05 by $0.03. Privia Health Group's revenue for the quarter was up 23.4% on a year-over-year basis.
Read the conference call transcript
.

Privia Health Group (PRVA) raised $351 million in an initial public offering (IPO) on Thursday, April 29th 2021. The company issued 19,500,000 shares at a price of $17.00-$19.00 per share. Goldman Sachs, J.P. Morgan, Credit Suisse, Piper Sandler and William Blair served as the underwriters for the IPO and Canaccord Genuity, Truist Securities, R. Seelaus & Co. and Siebert Williams Shank were co-managers.

Top institutional shareholders of Privia Health Group include Riverbridge Partners LLC (4.06%), State Street Corp (3.40%), Geode Capital Management LLC (2.18%) and Bank of New York Mellon Corp (1.77%). Insiders that own company stock include Adam Boehler, William M Sullivan, Jeffrey B Butler, Parth Mehrotra, David Mountcastle, Advisors LLC Mbd, Thomas Bartrum, Matthew Shawn Morris and Thomas A Mccarthy.
View institutional ownership trends
.

Shares of PRVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Privia Health Group investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), TotalEnergies (TTE) and Southern First Bancshares (SFST).

Company Calendar

Last Earnings
8/07/2025
Today
9/03/2025
Next Earnings (Estimated)
11/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MEDICAL INFO SYS
Sub-Industry
Healthcare
Current Symbol
NASDAQ:PRVA
CIK
1759655
Fax
N/A
Employees
1,140
Year Founded
N/A

Price Target and Rating

High Price Target
$35.00
Low Price Target
$23.00
Potential Upside/Downside
+21.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.93
Research Coverage
14 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.11
Trailing P/E Ratio
210.84
Forward P/E Ratio
165.64
P/E Growth
3.37
Net Income
$14.39 million
Net Margins
0.78%
Pretax Margin
1.57%
Return on Equity
2.13%
Return on Assets
1.25%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.65
Quick Ratio
1.65

Sales & Book Value

Annual Sales
$1.74 billion
Price / Sales
1.64
Cash Flow
$0.18 per share
Price / Cash Flow
127.69
Book Value
$5.98 per share
Price / Book
3.88

Miscellaneous

Outstanding Shares
122,730,000
Free Float
109,598,000
Market Cap
$2.85 billion
Optionable
Optionable
Beta
0.82
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:PRVA) was last updated on 9/3/2025 by MarketBeat.com Staff
From Our Partners